Search research articles
Contact Us
Filters
Showing results (131-140 of 137) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 137 results.
The Journal of Infectious Diseases
|
August 19, 2011
Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening
Timothy R Sterling, Bryan Lau, Jinbing Zhang, et al.
The Journal of Infectious Diseases
|
October 5, 2023
Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120
Zvavahera Mike Chirenje, Fatima Laher, One Dintwe, et al.
AIDS Research and Therapy
|
December 17, 2010
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?
Keri N Althoff, Kelly A Gebo, Stephen J Gange, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 23, 2009
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America
Steven G Deeks, Stephen J Gange, Mari M Kitahata, et al.
Cell
|
July 8, 2021
Translocated microbiome composition determines immunological outcome in treated HIV infection
Krystelle Nganou-Makamdop, Aarthi Talla, Ashish Arunkumar Sharma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 27, 2010
Late presentation for human immunodeficiency virus care in the United States and Canada
Keri N Althoff, Stephen J Gange, Marina B Klein, et al.
The New England Journal of Medicine
|
April 3, 2009
Effect of early versus deferred antiretroviral therapy for HIV on survival
Mari M Kitahata, Stephen J Gange, Alison G Abraham, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 137) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 137 results.
The Journal of Infectious Diseases
|
August 19, 2011
Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening
Timothy R Sterling, Bryan Lau, Jinbing Zhang, et al.
The Journal of Infectious Diseases
|
October 5, 2023
Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120
Zvavahera Mike Chirenje, Fatima Laher, One Dintwe, et al.
AIDS Research and Therapy
|
December 17, 2010
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?
Keri N Althoff, Kelly A Gebo, Stephen J Gange, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 23, 2009
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America
Steven G Deeks, Stephen J Gange, Mari M Kitahata, et al.
Cell
|
July 8, 2021
Translocated microbiome composition determines immunological outcome in treated HIV infection
Krystelle Nganou-Makamdop, Aarthi Talla, Ashish Arunkumar Sharma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 27, 2010
Late presentation for human immunodeficiency virus care in the United States and Canada
Keri N Althoff, Stephen J Gange, Marina B Klein, et al.
The New England Journal of Medicine
|
April 3, 2009
Effect of early versus deferred antiretroviral therapy for HIV on survival
Mari M Kitahata, Stephen J Gange, Alison G Abraham, et al.
Page
of 14